Hodgkin lymphoma

You have access
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in ¹⁸F-FDG PET scans of patients with classical Hodgkin lymphoma
Julia Driessen, Gerben JC Zwezerijnen, Heiko Schöder, Esther EE Drees, Marie José Kersten, Alison J Moskowitz, Craig H Moskowitz, Jakoba J Eertink, Henrica CW De Vet, Otto S Hoekstra, Joseé M Zijlstra and Ronald Boellaard

Journal of Nuclear Medicine January 6, 2022, jnumed.121.263067; DOI: https://doi.org/10.2967/jnumed.121.263067
You have access
¹⁸F-FDG PET/MRI for Staging and Interim Response Assessment in Pediatric and Adolescent Hodgkin Lymphoma: A Prospective Study with ¹⁸F-FDG PET/CT as the Reference Standard
Martijn V. Verhagen, Leon J. Menezes, Deena Neriman, Tom A. Watson, Shonit Punwani, Stuart A. Taylor, Ananth Shankar, Stephen Daw and Paul D. Humphries

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1524-1530; DOI: https://doi.org/10.2967/jnumed.120.260059
You have access
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease
Regine Kluge, Tim Wittig, Thomas W. Georgi, Lars Kurch, Osama Sabri, W. Hamish Wallace, Tomasz Klekawka, Ana Fernández-Teijeiro, Francesco Ceppi, Jonas Karlén, Jane Pears, Michaela Cepelová, Alexander Fosså, Auke Beishuizen, Lisa Lyngsie Hjalgrim, Dieter Körholz, Christine Mauz-Körholz and Dirk Hasenclever

Journal of Nuclear Medicine March 1, 2021, 62 (3) 338-341; DOI: https://doi.org/10.2967/jnumed.120.247924
You have access
Early ¹⁸F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab
Aiping Chen, Fatima-Zohra Mokrane, Lawrence H. Schwartz, Franck Morschhauser, Apasia Stamatoullas, Jean-Marc Schiano de Colella, Laetitia Vercellino, Olivier Casasnovas, Adrien Chauchet, Alain Delmer, Emmanuelle Nicolas-Virelizier, Hervé Ghesquières, Marie-Pierre Moles-Moreau, Anna Schmitt, Rémy Dulery, Krimo Bouabdallah, Cecile Borel, Mohamed Touati, Benedicte Deau-Fischer, Frédéric Peyrade, Romain-David Seban, Guillaume Manson, Philippe Armand, Roch Houot and Laurent Dercle

Journal of Nuclear Medicine May 1, 2020, 61 (5) 649-654; DOI: https://doi.org/10.2967/jnumed.119.232827
You have access
Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
Jasmin Mettler, Horst Müller, Conrad-Amadeus Voltin, Christian Baues, Bernd Klaeser, Alden Moccia, Peter Borchmann, Andreas Engert, Georg Kuhnert, Alexander Drzezga, Markus Dietlein and Carsten Kobe

Journal of Nuclear Medicine February 1, 2019, 60 (2) 207-211; DOI: https://doi.org/10.2967/jnumed.118.210047
You have access
¹⁸F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?
Thomas W. Georgi, Regine Kluge, Lars Kurch, Lidia Chavdarova, Dirk Hasenclever, Dietrich Stoevesandt, Tanja Pelz, Judith Landman-Parker, W. Hamish Wallace, Jonas Karlen, Ana Fernández-Teijeiro, Michaela Cepelova, Alexander Fosså, Walentyna Balwierz, Andishe Attarbaschi, Roland A. Ammann, Jane Pears, Andrea Hraskova, Anne Uyttebroeck, Auke Beishuizen, Karin Dieckmann, Thierry Leblanc, Stephen Daw, Julia Baumann, Dieter Körholz, Osama Sabri and Christine Mauz-Körholz

Journal of Nuclear Medicine October 1, 2018, 59 (10) 1524-1530; DOI: https://doi.org/10.2967/jnumed.117.205633
You have access
¹⁸F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti–Programmed Death 1 Immune Checkpoint Inhibitor
Laurent Dercle, Romain-David Seban, Julien Lazarovici, Lawrence H. Schwartz, Roch Houot, Samy Ammari, Alina Danu, Véronique Edeline, Aurélien Marabelle, Vincent Ribrag and Jean-Marie Michot

Journal of Nuclear Medicine January 1, 2018, 59 (1) 15-24; DOI: https://doi.org/10.2967/jnumed.117.193011
You have access
Interim ¹⁸F-FDG PET SUVmax Reduction Is Superior to Visual Analysis in Predicting Outcome Early in Hodgkin Lymphoma Patients
Cédric Rossi, Salim Kanoun, Alina Berriolo-Riedinger, Inna Dygai-Cochet, Olivier Humbert, Caroline Legouge, Marie Lorraine Chrétien, Jean-Noel Bastie, François Brunotte and René-Olivier Casasnovas

Journal of Nuclear Medicine April 1, 2014, 55 (4) 569-573; DOI: https://doi.org/10.2967/jnumed.113.130609
You have access
Interim ¹⁸F-FDG PET in Hodgkin Lymphoma: Would PET-Adapted Clinical Trials Lead to a Paradigm Shift?
Lale Kostakoglu and Andrea Gallamini

Journal of Nuclear Medicine July 1, 2013, 54 (7) 1082-1093; DOI: https://doi.org/10.2967/jnumed.113.120451
You have access
International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
Alberto Biggi, Andrea Gallamini, Stephane Chauvie, Martin Hutchings, Lale Kostakoglu, Michele Gregianin, Michel Meignan, Bogdan Malkowski, Michael S. Hofman and Sally F. Barrington

Journal of Nuclear Medicine May 1, 2013, 54 (5) 683-690; DOI: https://doi.org/10.2967/jnumed.112.110890

Main menu

User menu

Search

Hodgkin lymphoma